Anne Renteria, MD

Provider is directly employed by MedStar Health

Dr. Renteria is the medical director of the Stem Cell Transplantation and Cellular Immunotherapy program at MedStar Georgetown University Hospital in Washington, D.C. She is a board-certified medical oncologist and hematologist with a diverse medical background and deep expertise that spans the clinical, administrative, academic, and research realms.

As a Clinical Research Physician, she has conducted studies in more than 40 clinical trials. Most recently, Dr. Renteria was the senior medical director of Clinical Development—Hematology Oncology at Forma Therapeutics, a Novo Nordisk company.

On the hospital side, Dr. Renteria served as the medical director of the Acute Leukemia and Stem Cell Transplant and Cellular Therapy program at the Lipson Cancer Institute in Rochester, New York—a program she was instrumental in developing from the ground up. At The Mount Sinai Hospital in New York, she was an attending physician in both the Bone Marrow Transplant and Adult Leukemia programs. In both positions, she helped develop standards of practice for each service.

Dr. Renteria’s academic experience includes serving as the leader and assistant professor of Medicine at the Acute Lymphoblastic Leukemia Clinical Research program at the Tisch Cancer Institute, Mount Sinai School of Medicine; and assistant professor of Medicine, Hematology Oncology, at Boston University Medical School. Internationally known, Dr. Renteria has delivered lectures and presentations at numerous national and international conferences and has authored more than 50 peer-reviewed publications, books, book chapters, and abstracts.

Philosophy of care

Dr. Renteria exemplifies the spirit of cura personalis that defines care here at MedStar Georgetown. This translates as “care of the whole person” and encompasses treating the patient as a whole individual with unique challenges, needs, and possibilities—not merely as a byproduct of their symptoms.

Similarly, Dr. Renteria has spent her career in service to diverse communities and believes in taking the time to understand the unique factors that impact the quality of life in each locale. For her, this is critical to working collaboratively alongside the physicians in those communities to provide the most seamless continuum of care. “Building communication is of paramount importance—with referring physicians as well as community cancer care centers,” she says. “This is how we can broaden the net of services and treatment possibilities for our patients.”

About MedStar Georgetown Cancer Institute
MedStar Georgetown is part of the Georgetown Lombardi Comprehensive Cancer Center, which combines medical expertise, the latest therapies, and research across MedStar Health. Our research engine, the Georgetown Lombardi Comprehensive Cancer Center, is the only National Cancer Institute-designated comprehensive cancer center in the Washington, D.C., region. This partnership means we provide access to cutting-edge clinical trials and the latest breakthroughs in cancer care.